Signaturefd, LLC Agios Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 500 shares of AGIO stock, worth $27,770. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 488 2.46%

Holding current value

$27,770

Previous $21,000 4.76%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$41.19 - $49.72 $494 - $596	12 Added 2.46%	500 $22,000
Q2 2024 Jul 29, 2024	SELL	$27.55 - $48.83 $137 - $244	-5 Reduced 1.01%	488 $21,000
Q1 2024 May 03, 2024	SELL	$21.32 - $34.81 $4,264 - $6,962	-200 Reduced 28.86%	493 $14,000
Q4 2023 Jan 31, 2024	BUY	$19.97 - $24.53 $439 - $539	22 Added 3.28%	693 $15,000
Q3 2023 Nov 03, 2023	SELL	$24.36 - $28.18 $1,656 - $1,916	-68 Reduced 9.2%	671 $16,000
Q2 2023 Aug 01, 2023	SELL	$21.38 - $29.19 $598 - $817	-28 Reduced 3.65%	739 $20,000
Q1 2023 Apr 28, 2023	SELL	$21.74 - $30.93 $4,652 - $6,619	-214 Reduced 21.81%	767 $17,000
Q4 2022 Jan 27, 2023	SELL	$24.81 - $31.52 $545 - $693	-22 Reduced 2.19%	981 $27,000
Q3 2022 Nov 08, 2022	BUY	$19.51 - $34.14 $9,403 - $16,455	482 Added 92.51%	1,003 $28,000
Q2 2022 Aug 10, 2022	BUY	$17.06 - $31.42 $6,858 - $12,630	402 Added 337.82%	521 $12,000
Q1 2022 May 02, 2022	BUY	$26.68 - $34.81 $1,974 - $2,575	74 Added 164.44%	119 $3,000
Q4 2021 Jan 25, 2022	SELL	$29.58 - $49.78 $828 - $1,393	-28 Reduced 38.36%	45 $1,000
Q3 2021 Oct 28, 2021	SELL	$41.92 - $58.18 $4,401 - $6,108	-105 Reduced 58.99%	73 $3,000
Q2 2021 Jul 26, 2021	BUY	$52.06 - $61.27 $3,540 - $4,166	68 Added 61.82%	178 $10,000
Q1 2021 Apr 30, 2021	BUY	$44.23 - $57.5 $1,636 - $2,127	37 Added 50.68%	110 $6,000
Q3 2020 Nov 03, 2020	BUY	$33.87 - $55.93 $1,185 - $1,957	35 Added 92.11%	73 $3,000
Q2 2020 Jul 30, 2020	BUY	$34.45 - $53.48 $68 - $106	2 Added 5.56%	38 $2,000
Q1 2020 Apr 23, 2020	SELL	$31.52 - $53.81 $567 - $968	-18 Reduced 33.33%	36 $1,000
Q4 2019 Feb 05, 2020	BUY	$30.08 - $50.59 $1,082 - $1,821	36 Added 200.0%	54 $3,000
Q3 2019 Oct 16, 2019	SELL	$32.4 - $49.58 $1,004 - $1,536	-31 Reduced 63.27%	18 $1,000
Q2 2019 Jul 31, 2019	BUY	$46.17 - $68.1 $969 - $1,430	21 Added 75.0%	49 $2,000
Q1 2019 May 09, 2019	BUY	$45.92 - $67.67 $1,285 - $1,894	28 New	28 $2,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.04B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account